← Back to Clinical Trials
RecruitingNCT07233304

Complications of the Alveolar Opening Maneuver in Children on Mechanical Ventilation

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

ConditionPositive End-expiratory Pressure (PEEP)
SponsorHospital de Alta Complejidad en Red
Study TypeOBSERVATIONAL
PhaseN/A
Enrollment143
SexALL
Min Age1 Month
Max Age14 Years
Start Date2025-08-18
Completion2026-08
Interventions
Alveolar Opening Maneuver and PEEP Titration (AOM+P)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The objective of this research is to analyze the overall incidence of complications associated with a therapeutic maneuver known as alveolar opening and subsequent titration of positive end-expiratory pressure (PEEP) in pediatric patients with acute respiratory distress syndrome (ARDS). These procedures are part of the standard care provided in the Pediatric Intensive Care Unit (PICU) and are used to improve pulmonary oxygenation and respiratory mechanics. Through this study, we aim to gather information that will help improve the safety and effectiveness of these interventions in critically ill patients.

Eligibility Criteria

Inclusion criteria: * Patients under 14 years of age admitted to the HCANK PICU * More than 4 hours of invasive mechanical ventilation (IMV) * An oxygenation index (OI) ≥4 or an oxygen saturation index (OSI) ≥5 * Indication for ARM and PEEP as determined by the treating team Exclusion criteria: * Predicted body weight (PBW) \>45.5 kg * Recent pulmonary resection surgery (\<7 days) * Presence of broncho-pleural fistula or peri-tube leak \>25% of the tidal volume * Hemoglobin decline \<7 g/dL * Patients with congenital or acquired heart diseases with significant intracardiac shunt.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology